Catch by Gene enters agreement with C&S for HPV test kit

Catch by Gene (Pink Sheets:CBYG) has entered into an agreement to supply its reagent solutions to C&S Company Ltd commencing immediately in the initial amount of $300,000.

The contract deals with CBYG's proven test kit products that identifies sexually transmitted diseases including the Human Papilloma Virus ( HPV ) at an early stage.

Catch by Gene will begin supplying C&S 60,000 reagents a year and then anticipates increasing each year along with increased demand requirements in addition to other international distributors.

C&S who is but one of CBYG's distributors produces pharmaceuticals and medical equipment for physicians and has over 300 gynecologists in Korea that use their products.

The human papilloma virus ( HPV ) can be a leading cause of cervical cancer in women. The detection 'kit" is a lower cost HPV test for the affluent populations and now becoming available to the larger populations in Africa, Asia and Latin America.

CBYG is devoted to the research, development, manufacture and marketing of advanced in vitro nucleic acid assay with capture hybridization assay with multi-probes using microplate chemiluminescense or colorimetry method for the direct detection of several infectious pathogens (Hepatitis B virus, Human papilloma virus, Chlamydia trachomatis).